Sense Biodetection
Sense Biodetection Limited is a molecular diagnostics company .
Sense Biodetection has raised €27M across 2 funding rounds from 1 investor, most recently a Series B round in Nov 2021. Based in Abingdon, UK; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€27M
€27,108,534
Funding rounds
2
Investors
1
distinct backers
Active since
2019-10
latest 2021-11
Funding by year
EUR raised per yearSense Biodetection — funding by year — interactive chart.
Data table
| Sense Biodetection — funding by year | |
|---|---|
| 2019 | €14M |
| 2021 | €13M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-18 | Series B | €13M | Koch Disruptive Technologies | View deal → |
| 2019-10-01 | Other | €14M | — | View deal → |
Investors
1Related news
- Sense Biodetection Secures Additional $15M in Series B Financingfinsmes.com · 2021-11
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData